Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2040 of 5804
-
Cancer drug shows promise for Alzheimer's in tiny study
Disease control CompletedThis is an open-label, pilot study designed to explore whether daratumumab may have a clinically meaningful effect in patients with mild to moderate Alzheimer's disease.
Phase: PHASE2 • Sponsor: Marc L Gordon, MD • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Could a russian drug boost brain function in chronic ischemia?
Disease control CompletedThe purpose of this study is to evaluate safety and efficacy of sequential treatment with Mexidol® in patients with chronic cerebral ischemia (CCI).
Phase: PHASE3 • Sponsor: Pharmasoft • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New flow diverter device shows promise for brain aneurysm treatment
Disease control OngoingThe FIRST study is an observational, prospective, multi-center, international, single-arm, study. The aim of the study is to collect safety and efficacy information on the use of the silk vista and silk vista baby flow diverter in order to assess clinical safety and performance o…
Sponsor: Balt Extrusion • Aim: Disease control
Last updated Jun 26, 2026 18:15 UTC
-
New coaching model boosts cardiac rehab use in seniors
Disease control CompletedModified Application of Cardiac Rehabilitation for Older Adults (MACRO) responds to a critical underuse of cardiac rehabilitation in older adults with a coaching model that addresses issues related to aging as a means to better facilitate cardiac rehabilitation (CR). MACRO is a r…
Phase: NA • Sponsor: Daniel Forman, MD • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
MRI-Guided radiation aims to safely boost liver tumor treatment
Disease control Recruiting nowThe purpose of this trial is to identify a safe maximum tolerated dose level for MRI-guided Stereotactic Body Radiation Therapy (SBRT) treatment of bowel and liver metastases, respectively. Eligible participants will be on study for up to 12 months.
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Which drug best prevents eye muscle weakness from spreading? new study aims to find out
Disease control Recruiting nowThis study collects the clinical data of new-onset ocular myasthenia gravis (OMG) patients, assesses outcomes and adverse effects of different treatment options, and evaluate risk factors of conversion to generalized MG(GMG).
Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Brittle bone breakthrough? drug may restore hearing
Disease control Recruiting nowOsteogenesis Imperfecta-related hearing loss usually occurs in individuals with mild (type I) OI and is much earlier in onset than age-related hearing loss, with the majority of individuals experiencing some minor hearing loss in their 20s. Bisphosphonates have been successfully …
Phase: PHASE4 • Sponsor: Hospital for Special Surgery, New York • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New program aims to close colorectal cancer screening gap for Low-Income and minority communities
Prevention OngoingThis clinical trial implements research strategies to increase colorectal cancer (CRC) screening rates among low income and ethnic minority groups. CRC is the second most common cause of cancer mortality in the United States and disproportionately burdens low income and ethnic mi…
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 07:57 UTC
-
Surgical sleuthing: new method hunts for hidden cancer origins
Diagnosis OngoingSquamous cell carcinoma (SCC) is a cancer that originates from the cells lining the body and can spread into the lymph glands and beyond. Some patients first present with an SCC which has moved to the lymph glands of the neck. Clinical examination and imaging investigations are p…
Sponsor: Royal Marsden NHS Foundation Trust • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC
-
New cocktail of pain drugs aims to slash opioid use after major cancer surgery
Symptom relief CompletedThis study will be a randomized, prospective study comparing Pain Management Arm A and Pain Management Arm B. Arm A will have scheduled Tylenol with opioids available as needed (PRN) in the peri-operative period. Arm B will undergo scheduled Gabapentin, Ketorolac and Tylenol as w…
Phase: PHASE4 • Sponsor: University of Kansas Medical Center • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
New drug may help liver transplant patients avoid bleeding complications
Disease control CompletedSevere post-transplantation thrombocytopenia (platelet count \<30×10⁹/L) occurs frequently after liver transplantation (LT) and is associated with increased bleeding risk, allograft dysfunction, and transfusion-related complications. Avatrombopag, an oral thrombopoietin receptor …
Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Brain fluid MRI could spot Alzheimer's and hydrocephalus earlier
Diagnosis Recruiting nowThe Researchers are trying to test a MR imaging method for detection of Cerebral Spinal Fluid (CSF) flow in the brain to help diagnosis and better understand diseases that affect brain function.
Phase: NA • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 08:08 UTC
-
New antibody combo takes on advanced cancers in first human trial
Disease control CompletedLVGN6051 is a humanized monoclonal antibody that specifically binds to CD137, and acts as an agonist against CD137. This first in human study of LVGN6051 is designed to establish the maximum tolerated dose (MTD) and/or the recommended dose for expansion (RDE) as well as the reco…
Phase: PHASE1 • Sponsor: Lyvgen Biopharma Holdings Limited • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Brain stimulator that thinks on its feet shows promise for Parkinson's freezing
Disease control CompletedDeep Brain Stimulation of the subthalamic nucleus (STN) has become a standard of care, FDA-approved treatment for Parkinson's disease, with stimulation delivered at a constant amplitude and voltage, operating in an open-loop fashion that does not respond to a patient's current st…
Phase: NA • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Brain-Scan showdown: which test best finds seizure hotspots?
Knowledge-focused Recruiting nowDrug-resistant partial epilepsies are disabling diseases for which surgical treatment may be indicated. The determination of the area to be operated (or 'epileptogenic zone') is based on a bundle of clinical arguments and neuroimaging, having a direct impact on surgical success. …
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Vibrating device offers new hope for premature babies with breathing pauses
Symptom relief CompletedThe goal of the SENSITACT system is to activate an adaptive kinesthetic stimulation to treat apnea-bradycardia events on preterm infants, while minimizing deleterious effects, in particular arousals that can be due either to respiratory efforts or to kinesthetic stimulation itsel…
Phase: NA • Sponsor: Rennes University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Brain pacemaker study aims to shake up essential tremor treatment
Disease control Recruiting nowTo compile characteristics of real-world outcomes for Boston Scientific Corporation's commercially approved Deep Brain Stimulation (DBS) Systems, when used according to the applicable Directions for Use, for the treatment of Essential Tremor.
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Blood test may replace invasive heart scans
Diagnosis OngoingA considerable proportion of patients with clinically suspected coronary artery disease (CAD) do not have angiographic signs of luminal narrowing caused by coronary atherosclerosis. In patients with suspected CAD, we will assess the ability of cardiovascular biomarkers to identif…
Sponsor: University Hospital, Akershus • Aim: Diagnosis
Last updated Jun 27, 2026 13:04 UTC
-
Mind over migraine: brain network may explain why some expect side effects
Knowledge-focused CompletedPeople with migraine sometimes experience symptoms because they expect a treatment to cause side effects. This is known as the "nocebo effect". Unlike a drug side effect, a nocebo effect is triggered by negative expectations rather than by the treatment itself. Nocebo effects can…
Phase: NA • Sponsor: Ioanna Spanou • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Can intensive early intervention boost social skills in kids with autism?
Symptom relief Recruiting nowThe purpose of this study is to examine the effectiveness of a 12-week early intervention program that will include 12 weekly hours in an intensive center-based preschool environment or in the home to treat social communication deficits in children with developmental disorders. T…
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC